BGLAP and hyperparathyroidism: In contrast, transgenic mice with osteoblasts specific (osteocalcin promoter) over-expression of TGF-β2 show a dramatic, age-dependent loss of bone mass similar to that seen in osteoporosis and hyperparathyroidism [33].